I. Introduction
Adenosine deaminase (EC 3.5.4.4) (ADA) is a key enzyme of purine metabolism that catalyzes the irreversible conversion of the physiologically active nucleosides adenosine and 2'-deoxyadenosine into biologically less active ones, inosine and 2'-deoxyinosine, respectively. This ubiquitous enzyme has been found in all vertebrate tissues; however, the levels of activity and patterns of expression vary between tissues and species. In humans, the highest ADA expression is found in the thymus and other lymphoid tissues, with high activity also found in the villi of epithelial lining cells of the duodenum and maternal deciduas.
It has been suggested that ADA participates in various pathophysiological processes, such as differentiation and maturation of the lymphoid system, differentiation of epithelial cells, neurotransmission, and functioning of mature decidual cells, besides the degradation of adenosine. Further, ADA deficiency in humans is known as one of the causes of severe combined immunodeficiency (SCID), characterized by T and B cell lymphopenia, giving rise to multiple recurrent infections. Conversely, several diseases showing supernormal ADA activity are also known, which leads to an increased breakdown of adenosine, and may play a deleterious role in hypertension or ischemic injury. Previous reports have described the histochemical localization of this enzyme in various animal tissues, such as those from rats and calves [6] .
As for tissues, immunohistochemical localization of ADA studies have been performed extensively using tissues from the brain [13, 22] and digestive tract [7, 25] . However, immunohistochemical localization of ADA has not been performed with human tissues, except for the thymus [4] . In humans, 3 ADA isozymes with differing molecular weight, kinetic properties, and tissue distributions have been identified: 1) ADA 1 (small form of the enzyme); 2) ADA 1+com-bining protein; 3) ADA 2 (large form of the enzyme). Therefore, we investigated the distribution of ADA 1 in various human tissues using immunohistochemical staining procedures, since the physiological role played by ADA in various tissues is not clear and the cell-specific tissue distribution of Correspondence to: Yuji Moriwaki, M.D., Division of Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya, Hyogo 663-8501, Japan. E-mail: t-ohk@hyo-med.ac.jp ADA 1 is of biological importance for the elucidation of its functional role. Moreover, it is hazardous to transpose data from one species to another [2] .
II. Materials and Methods

Tissue collection
After informed consent was obtained from the family, tissue samples were obtained from corpses as soon as possible after death. Tissue specimens were fixed in 4% paraformaldehyde-PBS (0.01 M phosphate-buffered saline, pH 7.4), embedded in paraffin at 60°C, and subjected to immunohistochemical staining.
Antibody preparation and specificity testing
Keyhole limpet hemocyanin (KLH)-peptide conjugate was employed as an antigen to construct a human ADA-1 antibody. The synthetic peptide used was Ser-Phe-LeuPro-Glu-Asp-Glu-Lys-Arg-Glu-Leu-Leu, which was determined from the primary amino acid sequence of human ADA (small form, ADA 1) [9] . KLH was used as the carrier protein, and 200 mg of KLH-peptide conjugate with Freund's complete adjuvant was subcutaneously injected into a male white rabbit. Following that, immunization with 100 mg of KLH-peptide conjugate with Freund's incomplete adjuvant was repeated 5 times at two-week intervals. Seven days after the last immunization, blood was withdrawn, centrifuged, separated by centrifugation at 1700´g for 10 min, and then warmed to 56°C for 30 min. The resultant serum was saturated with 50% ammonium sulfate, dialyzed against PBS, and used as a polyclonal antibody against human ADA. The specificity of the antibody was fully confirmed by Western blot analysis. After electrophoresis, tissue cytoplasmic protein was transferred electrophoretically from a polyacrylamide gel to a PVDF membrane and the membrane was blocked overnight at 4°C in Block Ace (Dainippon Pharmaceutical Co. Ltd., Osaka, Japan). After being rinsed with TBS containing 0.05% Tween 20 (TBST), the PVDF membrane was incubated for 1 hr at room temperature with 4 mg/mL of polyclonal antibody against human ADA in 25% Block Ace. The membrane was then washed 3 times with TBST for 10 min each time, and incubated at room temperature for 30 min with a labeled polymer (ENVISION+, Dako Corp., Carpinteria, CA, USA) and washed again 3 times with rinse buffer, 10 min each time. ADA protein was then visualized using a Liquid DAB substrate-chromogen system (Dako Corp.).
Immunohistochemical procedures
Immunoperoxidase staining
Immunolocalization of ADA 1 in the tissue sections was performed using avidin-biotin peroxidase complex (ABC) techniques. Deparaffinized tissue sections were treated with 3% H 2 O 2 in 50 mM of Tris-buffered saline (TBS), pH 7.4, for 5 min to block any endogenous peroxidase activity in the tissues. After 3 washes with TBS for 5 min, the tissue sections were incubated with a Blocking kit reagent (Vector Laboratories, Burlingame, CA, USA) consisting of an avidin D solution and a biotin solution for 15 min to block nonspecific binding of the biotin/avidin system reagents. After 3 washes with TBS for 5 min, sections were placed in Block Ace for 45 min to reduce nonspecific staining of the bridging antibody, and then incubated overnight with primary rabbit anti-ADA antibody (50% saturated ammonium sulfate fraction) at a 1:40 dilution in 25% blocking solution at 4°C. After being washed 3 times for 5 min in TBS including 0.05% (v/v) Tween 20 (TBST), the sections were incubated at room temperature for 30 min with biotinylated anti-rabbit IgG antibody (Vector Laboratories) at a 1:200 dilution in TBS. After additional washing with TBST 3 times for 5 min, the sections were incubated for 30 min at room temperature with avidin-biotin complex (Vectastain ABC Elite kit, Vector Laboratories). Following washing with TBST 3 times for 5 min, the sections were placed in TBS containing 0.03% H 2 O 2 and 0.03% DAB for 5 min. Counterstaining Fig. 1 . Immunoblotting of adenosine deaminase on 12.5% SDS-PAGE. A single band was observed at the molecular weight of electrophoresed erythrocyte adenosine deaminase. Hemolysate containing 45 mg of hemoglobin was electrophoresed and an immunoblot analysis was performed using anti-human adenosine deaminase antibody. Molecular weight standards were 14,300 for lysozyme, 18,400 for b-lactoglobulin, 29,000 for carbonic anhydrase, 68,000 for bovine serum albumin, and 200,000 for myosin (H-chain).
was performed with Mayer hemalum solution (Diagnostica Merck, Darmstadt, Germany). Finally, after a wash in TBS, the sections were dehydrated in a graded ethanol series and coverslipped with a resin-based permanent mounting medium (Shandon/Lipshaw Co., Pittsburgh, PA, USA). As controls for ADA immunostaining, some sections were incubated in the same manner, except that the primary antibody was replaced by normal rabbit serum (50% saturated ammonium sulfate fraction).
Immunofluorescence
Immunolocalization of ADA 1 in lymphocytes was performed according to the method of Franco et al. (1990) [15] . For the experiments, peripheral blood lymphocytes were harvested by centrifugation (1700´g for 30 min) using Ficoll-Paque (Pharmacia Biotech AB, Uppsala, Sweden). Lymphocytes were washed in PBS, blotted onto glass slides by cytospin, fixed in 4% paraformaldehyde, and dried. The glass slides were washed with solution A (PBS containing 
III. Results
Specificity testing of antibody
The specificity of the polyclonal antibody against ADA 1 was examined by immunoblotting. The antibody reacted with only one protein band corresponding to the molecular weight (31,000 to 35,000) [1, 10, 21] of ADA 1 of human hemolysate (Fig. 1) .
Immunohistochemistry of ADA
The distribution of ADA 1 reactivity observed in various tissues was as follows.
Peripheral lymphocytes
Fluorescein fluorescence of lymphocytes demonstrated that ADA 1 localization was more intense on the surface membrane than in the cells (Fig. 2a) .
Lymph node
Both the cortex and medulla were diffusely immunostained, whereas lymphocytes were diffusely immunostained with an uneven distribution. The perifollicular area of the lymph node exhibited populations of ADA 1-positive cells, whereas the follicular area exhibited no reactivity against the ADA 1 antibody. The vascular endothelia were intensely stained (Fig. 3a) .
Spleen
The red pulp (perifollicular area) of the spleen exhibited populations of ADA 1-positive cells, whereas the white pulp (follicular area) exhibited no reactivity against the ADA 1 antibody. The endothelia of the cord and red blood cells were also immunostained against the ADA 1 antibody (Fig. 4a) .
Esophagus
The epithelium, especially that in the keratinized layer of the esophagus, was intensely immunostained. The esophageal muscle was also moderately stained (Fig. 5a ).
Stomach
Surface epithelia, gastric glands, and lamina musclaris mucosa were strongly immunostained. Nonspecific staining was observed in the gastric glands (Fig. 6a) .
Small intestine
The small intestine was diffusely immunostained. The surface epithelia, including those of the intestinal glands, were intensely immunostained. The lamina propria, tela submucosa, circular and longitudinal muscle layer, and tunica serosa also contained ADA 1-positive cells. However, the solitary lymphatic nodule was not immunostained (Fig. 7a) .
Large intestine
In the large intestine, the surface epithelia and intestinal glands were immunostained as in the small intestine, though the intensity was weaker (Fig. 8a) . was intensely immunostained. The esophageal muscle was moderately stained (a). ept, epithelium; lmm, lamina musclaris mucosa. (b) shows the corresponding control. Original magnification ca. ´10. Fig. 6 . Immunohistochemical localization of ADA in the stomach. The surface epithelia and lamina musclaris mucosa were strongly immunostained (a). Nonspecific staining of gastric glands was also observed, despite prior incubation with a blocking agent (b). ept, epithelium; gpt, gastric pit. Original magnification ca. ´37.5.
Liver
The hepatocytes displayed a diffuse and even immunostaining with moderate intensity. The endothelial cells of the sinusoid and Kupffer stellate cells were intensely stained, as were the endothelial lining cells of the portal vein. The interlobar artery and bile ducts were also immunostained against the ADA 1 antibody (Fig. 9a, c) .
Kidney
The proximal, distal, and collecting tubules exhibited positive immunostaining with varying intensity. The endothelial cells in the glomerular tuft were also stained for ADA 1, though weaker than the epithelial cells in the tubules. Neither the vas afferens nor vas efferens was immunostained against the ADA 1 antibody. However, red blood cells were immunostained (Fig. 10a, c) .
Lung
The surface epithelia of the trachea were intensely stained, while the lamina propria and perichondrium were moderately stained. The alveolar cells and veins were intensely stained, and some of the tracheal cartilage cells displayed a moderate reaction (Fig. 11a, c) .
Heart
The cardiac muscle cells and endothelial lining cells were immunostained for ADA 1 (Fig. 12a) .
Immunohistochemical controls
Sections in which the ADA 1 antiserum was replaced by preimmune serum were totally negative (Fig. 2b-Fig.  12b, Fig. 9d-Fig. 11d) . Fig. 7 . Immunohistochemical localization of ADA in the small intestine. The small intestine was diffusely immunostained. The lamina propria, tela submucosa, circular and longitudinal muscles, and tunica serosa were moderately immunostained. In contrast, the surface epithelium and intestinal glands were strongly immunostained (a). The solitary lymphatic nodule was not immunostained. git, intestinal gland; lmm, lamina musclaris mucosa; tsm, tela submucosa. (b) shows the corresponding control. Original magnification ca. ´25. Fig. 8 . Immunohistochemical localization of ADA in the large intestine (sigmoid colon). In the large intestine, the surface epithelia and intestinal glands were immunostained as in the small intestine, though the intensity was weaker (a). git, intestinal gland; lmm, lamina musclaris mucosa. (b) shows the corresponding control. Original magnification ca. ´25.
IV. Discussion
The histochemical localization of ADA has been investigated in various tissues and species [4, 5, 6, 22, 26] . However, the immunohistochemical localization of ADA in human tissues has not been extensively investigated, except for a few studies of hematopoietic and lymphatic systems [4, 5] . Although ADA is considered to be a housekeeping enzyme for purine metabolism, the present study demonstrated the cell-specific localization of ADA 1 in a wide range of human tissues. Therefore, these cells might be involved in the inactivation and turnover of adenosine through ADA, which degrades adenosine to inosine. Since ADA is most abundantly expressed in the thymus, it is believed that the major physiologic role of the enzyme is development of T-cells [18] . However, the ubiquitous tissue localization of ADA 1 in humans suggests a mechanism governing adenosine metabolism as well as the immune process.
Considering the significance of the extra-immunological tissue localization of ADA, it is noteworthy that adenosine has been proposed as a key mediator of many biological processes [12] , such as vasodilation, release of nitric oxide from vascular endothelial cells, inhibition of platelet aggregation and adhesion, neurological transmission, and renin release. ADA is expected to play a role in these processes, together with the adenosine-generating enzyme, 5'-nucleotidase. ADA is thought to be a cytosolic enzyme. However, as demonstrated in the present and a previous study [16] , ADA can also be considered as an ecto-enzyme interacting with CD26. According to our histochemical results, ADA 1 seems to be related to physiological functions. The localization of ADA 1 in the absorptive area of the (small) intestines provides the initial mechanism for removal of lymphotoxic adenosine entering the body from the gut, supporting the results of Franco et al. [14] , which showed that adenosine is degraded by extracellular ADA in the rat duodenum. The localization of ADA 1 in the lamina propria may be correlated with the effect of ADA inhibitors on the relaxing action of adenosine in the smooth muscle tissues of the intestine [3] . However, no definite evidence of defective digestive physiology has been demonstrated in ADA deficient humans [7] , despite a lack of lymphoid cells. In addition, ADA 1 in the liver may play a role in the removal of adenosine from blood that is derived from the gut, so that other tissues of the circulatory system, besides the portal vein, are not exposed to excess adenosine. Further, ADA 1 in the lung may play a role in decreasing the adenosine concentration in blood before entering the left ventricle and coronary circulation of the heart. ADA 1 in the other tissues may play a similar role.
The main function of ADA in lymphocytes appears to be the protection of these cells from the toxic effects of high concentrations of adenosine and deoxyadenosine [8, 12] . In addition, the cell surface localization of ADA 1 (ecto-ADA) in lymphocytes may suggest a role of this enzyme in the transmission of signals by interacting with cell surface receptors, CD26 and A 1 adenosine receptors, or in the process of ontogenesis and maturation of immunocompetent cells [16] . Moreover, ADA seems to be associated with the differentiation of epithelial cells [24] , monocyte maturation [11] , neurotransmission [20] , and the maintenance of gestation [19] . On the other hand, erythrocyte-derived ADA may have a deleterious effect by increasing the risk of vasoocclusion through the degradation of adenosine [17] .
The adenosine producing enzyme, 5'-nucleotidase, has been demonstrated to be widely distributed in various tissues with a topology parallel to that of the adenosine degrading enzyme, ADA [13, 23] . Therefore, it is suggested that ADA and 5'-nucleotidase act as a coupled enzyme system in biosynthetic pathways, and their co-localization may play a crucial role in an adaptive system in the generation and elimination of adenosine.
In summary, the present study is the first known to identify and localize ADA 1 in human tissues by immunohistochemistry, using an anti-human ADA 1 polyclonal antibody. Although the present results may be descriptive and the wide tissue distribution of ADA 1 does not provide an immediate clue to its biological function, its expression in these selective sites may be of significance and could provide evidence of its action. Further investigation is needed to fully explain the role of this enzyme. Fig. 11 . Immunohistochemical localization of ADA in the lung. The surface epithelia of the trachea were intensely immunostained, while the lamina propria and perichondrium were moderately immunostained. Some of the tracheal cartilage cells (arrow) also displayed a moderate reaction (a). Nonspecific staining of the tracheal glands was also demonstrated, despite prior incubation with a blocking agent (b). The alveolar cells were intensely stained (c). No reaction products were seen in the control sections (d). ept, epithelium; lpr, lamina propria; glt, tracheal gland; ves, vessel; alv, alveolus. Original magnification ca. ´25. Fig. 12 . Immunohistochemical localization of ADA in the heart. The cardiac muscle cells and endothelial lining cells (arrow) were immunostained for ADA (a). No reaction products were observed in the control sections (b). Original magnification ca. ´75.
